Cord blood S100B protein in growth-restricted newborns
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This study measures a protein called S100B in umbilical cord blood to learn more about brain development in newborns with fetal growth restriction (FGR), a condition where a baby is smaller than expected. Understanding this protein could help doctors identify babies who may need extra support after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 37 weeks pregnant with a single baby (not twins or more).
- Your pregnancy must be complicated by fetal growth restriction (your baby is smaller than expected).
- You cannot smoke or use illegal drugs.
- You cannot have had diabetes before becoming pregnant.
- You cannot have depression that requires medication.
- The amniotic sac cannot have been broken for more than 15 hours, and labor cannot last longer than 15 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures a protein (S100B) in cord blood from babies who had or did not need a blood transfusion in the womb for hemolytic disease. It looks for possible markers of brain health.
This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.
This study uses a special type of MRI (magnetic resonance imaging) to look at the brain development of babies who are growing slowly in the womb. The goal is to see if this scan can help doctors better understand this condition and how to care for these babies.
This study looks at whether a protein called fetuin-B in the mother's blood is different in pregnancies where the baby is growing slower than expected. It may help doctors understand and manage this condition.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
This study looks at how blood flow measurements (Doppler) in the baby's ductus venosus (a small blood vessel near the heart) relate to pregnancy outcomes, especially for babies who are smaller than expected. If you join, researchers will track these measurements and your baby's health to see if they can predict better or worse outcomes.
Hear when a new Hypoxia-Ischemia, Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.